Market Tracker

06/21 5:15pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

15.90
Delayed Data
As of Jun 21
 -0.05 / -0.31%
Today’s Change
8.15
Today|||52-Week Range
24.45
-14.97%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close15.95
Today’s open16.10
Day’s range15.80 - 16.20
Volume871,059
Average volume (3 months)1,606,749
Market cap$1.2B
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)+38.01%
Earnings growth (this year)-35.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.04%
P/E ratioNM
Price/Sales3,008.76
Price/Book6.15

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-2.63-8.71%
CLLSCellectis SA-0.18-0.58%
XNCRXencor Inc-0.31-0.77%
DERMDermira Inc-0.05-0.46%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$327.0K
Annual profit (last year)-$95.2M
Net profit margin-29,099.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts